Compounds > erythromycin
Page last updated: 2024-08-21

erythromycin and camptothecin

erythromycin has been researched along with camptothecin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
de Bruijn, P; de Jong, FA; Figg, WD; Friberg, LE; Graveland, WJ; Lepper, ER; Mathijssen, RH; Rietveld, T; Sparreboom, A; van Schaik, RH; Verweij, J1
Cendros, JM; Evans, TR; Falk, S; Graham, JS; Samuel, LM1

Other Studies

4 other study(ies) available for erythromycin and camptothecin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes.
    Journal of the National Cancer Institute, 2004, Nov-03, Volume: 96, Issue:21

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Breath Tests; Camptothecin; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Confidence Intervals; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Enzyme Inhibitors; Erythromycin; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucuronosyltransferase; Humans; Irinotecan; Male; Midazolam; Middle Aged; Phenotype; Predictive Value of Tests; Prospective Studies

2004
A multi-centre dose-escalation and pharmacokinetic study of diflomotecan in patients with advanced malignancy.
    Cancer chemotherapy and pharmacology, 2009, Volume: 63, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Breath Tests; Camptothecin; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Erythromycin; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Staging; Neoplasms; Prognosis; Survival Rate; Tissue Distribution; Treatment Outcome; Young Adult

2009